A detailed history of Man Group PLC transactions in Repligen Corp stock. As of the latest transaction made, Man Group PLC holds 53,879 shares of RGEN stock, worth $8.67 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
53,879
Holding current value
$8.67 Million
% of portfolio
0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $6.45 Million - $9.02 Million
53,879 New
53,879 $8.02 Million
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $1.1 Million - $1.44 Million
7,977 Added 209.92%
11,777 $1.67 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $586,188 - $752,780
3,800 New
3,800 $639,000
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $1.01 Million - $1.36 Million
-7,214 Reduced 43.16%
9,502 $1.54 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $4.72 Million - $7.56 Million
-29,296 Reduced 63.67%
16,716 $3.14 Million
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $3.81 Million - $4.68 Million
15,384 Added 50.23%
46,012 $12.2 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $1.26 Million - $2.09 Million
-6,448 Reduced 17.39%
30,628 $8.85 Million
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $1.77 Million - $2.36 Million
10,669 Added 40.4%
37,076 $7.4 Million
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $93,251 - $116,976
-517 Reduced 1.92%
26,407 $5.13 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $1.58 Million - $2.2 Million
-10,644 Reduced 28.33%
26,924 $5.16 Million
Q3 2020

Nov 16, 2020

SELL
$122.51 - $158.27 $322,078 - $416,091
-2,629 Reduced 6.54%
37,568 $5.54 Million
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $1.69 Million - $2.51 Million
17,880 Added 80.12%
40,197 $4.97 Million
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $6.89 Million - $8.86 Million
-81,142 Reduced 78.43%
22,317 $2.15 Million
Q4 2019

Feb 18, 2020

BUY
$73.84 - $93.08 $3.21 Million - $4.05 Million
43,530 Added 72.64%
103,459 $9.57 Million
Q3 2019

Nov 14, 2019

SELL
$76.65 - $95.51 $268,275 - $334,285
-3,500 Reduced 5.52%
59,929 $4.6 Million
Q2 2019

Aug 14, 2019

SELL
$54.2 - $85.95 $341,460 - $541,485
-6,300 Reduced 9.03%
63,429 $5.45 Million
Q1 2019

May 15, 2019

BUY
$49.45 - $62.8 $3.45 Million - $4.38 Million
69,729 New
69,729 $4.12 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.93B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.